Strategies for the Management of Atrial Fibrillation in patiEnts Receiving HemoDialysis
Conditions: Atrial Fibrillation; End Stage Renal Failure on Dialysis Interventions: Drug: Warfarin; Drug: Apixaban; Other: No oral anticoagulation Sponsors: St. Michael's Hospital, Toronto; Canadian Institutes of Health Research (CIHR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atrial Fibrillation | Coumadin | Dialysis | Hemodialysis | Hospitals | Research | Warfarin